CERT
NASD Certara, Inc.$9.36 ↑ +0.00 (+0.00%) Trading Up from the previous close of $9.36, $0.09 below the day’s high of $9.45
- YTD change
- +6.24%
- vs 20-day SMA
- +10.86%
- vs 200-day SMA
- +30.35%
Price ranges
Price & Performance
+3.90 (+71.43%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 79.4% away from all-time highs of $45.48
- CERT is up 6% since the beginning of the year
- CERT is down 31% over the past 12 months
- CERT is up 13% over the past 1 month
- 30% of all CERT investors are betting against CERT
CERT reads neutral: price sits above both the 20- and 200-day averages, the 12-month move is -28.4%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- +5.29%
- vs 8-day SMA
- +3.43%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017 and is headquartered in Radnor, PA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.